Clinical Trial Update: A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia [Phase 3]

View source ↗

Summary

This clinical trial update reports results from a Phase 3 study of intravenous Mircera in hemodialysis patients with chronic renal anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-07-19